UK markets closed
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • FTSE 250

    19,545.70
    +5.36 (+0.03%)
     
  • AIM

    847.07
    +2.68 (+0.32%)
     
  • GBP/EUR

    1.1629
    -0.0005 (-0.04%)
     
  • GBP/USD

    1.2091
    -0.0023 (-0.19%)
     
  • BTC-GBP

    13,712.83
    -68.73 (-0.50%)
     
  • CMC Crypto 200

    386.97
    +4.32 (+1.13%)
     
  • S&P 500

    4,026.12
    -1.14 (-0.03%)
     
  • DOW

    34,347.03
    +152.97 (+0.45%)
     
  • CRUDE OIL

    76.28
    -1.66 (-2.13%)
     
  • GOLD FUTURES

    1,754.00
    +8.40 (+0.48%)
     
  • NIKKEI 225

    28,283.03
    -100.06 (-0.35%)
     
  • HANG SENG

    17,573.58
    -87.32 (-0.49%)
     
  • DAX

    14,541.38
    +1.82 (+0.01%)
     
  • CAC 40

    6,712.48
    +5.16 (+0.08%)
     

Global Therapeutic Drug Monitoring Market to Reach $3.2 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Therapeutic Drug Monitoring estimated at US$1. 8 Billion in the year 2020, is projected to reach a revised size of US$3. 2 Billion by 2027, growing at aCAGR of 8.

New York, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Therapeutic Drug Monitoring Industry" - https://www.reportlinker.com/p06033114/?utm_source=GNW
3% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 8.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Equipment segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $498.8 Million, While China is Forecast to Grow at 13.2% CAGR

The Therapeutic Drug Monitoring market in the U.S. is estimated at US$498.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$734.4 Million by the year 2027 trailing a CAGR of 13.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Select Competitors (Total 42 Featured) -
Aalto Scientific
Abbott Laboratories
Apdia Group
Ark Diagnostics
Biomérieux
Bio-Rad Laboratories
Biotez Berlin Buch
Bühlmann Laboratories
Cambridge Life Sciences
Chromsystems Instruments & Chemicals
Danaher Corporation
Diasystem Scandinavia
Eagle Biosciences
Exagen
F. Hoffmann-La Roche
Grifols
Immundiagnostik
Jasem Laboratory Systems And Solutions
Randox Laboratories
R-Biopharm
Sekisui Medical
Siemens Healthineers
Theradiag
Thermo Fisher Scientific
Utak


Read the full report: https://www.reportlinker.com/p06033114/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Therapeutic Drug Monitoring - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Therapeutic Drug Monitoring
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Therapeutic Drug
Monitoring by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Equipment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Equipment by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Equipment by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Immunoassays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Immunoassays by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Immunoassays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Chromatography-MS by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Chromatography-MS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Chromatography-MS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Hospital Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Hospital Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Hospital Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Commercial / Private Laboratories by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Commercial / Private
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Commercial / Private
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Therapeutic Drug Monitoring Market Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
Table 26: USA Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 27: USA Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 28: USA 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 29: USA Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 30: USA Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 31: USA 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 32: USA Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 33: USA Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 34: USA 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 36: Canada Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 37: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 38: Canada Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 40: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 41: Canada Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 42: Canada Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 43: Canada 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

JAPAN
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 45: Japan Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 46: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 47: Japan Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 50: Japan Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 51: Japan Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 52: Japan 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

CHINA
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Table 53: China Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 54: China Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 55: China 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 56: China Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 57: China Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 58: China 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 59: China Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 60: China Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 61: China 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

EUROPE
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 62: Europe Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 63: Europe Historic Review for Therapeutic Drug
Monitoring by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 64: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027

Table 65: Europe Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 66: Europe Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 67: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 68: Europe Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 69: Europe Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 70: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 71: Europe Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 72: Europe Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 73: Europe 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

FRANCE
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 74: France Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 75: France Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 76: France 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 77: France Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 78: France Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 79: France 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 80: France Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 81: France Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 82: France 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

GERMANY
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 83: Germany Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 84: Germany Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 85: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 86: Germany Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 87: Germany Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 88: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 89: Germany Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 90: Germany Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 91: Germany 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

ITALY
Table 92: Italy Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 93: Italy Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 94: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 95: Italy Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 96: Italy Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 97: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 98: Italy Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 99: Italy Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 100: Italy 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

UNITED KINGDOM
Therapeutic Drug Monitoring Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2022
(E)
Table 101: UK Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 102: UK Historic Review for Therapeutic Drug Monitoring
by Product - Consumables and Equipment Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 103: UK 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 104: UK Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 105: UK Historic Review for Therapeutic Drug Monitoring
by Technology - Immunoassays and Chromatography-MS Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 106: UK 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 107: UK Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 108: UK Historic Review for Therapeutic Drug Monitoring
by End-Use - Hospital Laboratories, Commercial / Private
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 109: UK 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

SPAIN
Table 110: Spain Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 111: Spain Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 112: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 113: Spain Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 114: Spain Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 115: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 116: Spain Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 117: Spain Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 118: Spain 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

RUSSIA
Table 119: Russia Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Product - Consumables and
Equipment - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 120: Russia Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 121: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by Product - Percentage Breakdown of Value Sales for
Consumables and Equipment for the Years 2012, 2021 & 2027

Table 122: Russia Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by Technology - Immunoassays and
Chromatography-MS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 123: Russia Historic Review for Therapeutic Drug
Monitoring by Technology - Immunoassays and Chromatography-MS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 124: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by Technology - Percentage Breakdown of Value Sales
for Immunoassays and Chromatography-MS for the Years 2012, 2021 &
2027

Table 125: Russia Recent Past, Current & Future Analysis for
Therapeutic Drug Monitoring by End-Use - Hospital Laboratories,
Commercial / Private Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 126: Russia Historic Review for Therapeutic Drug
Monitoring by End-Use - Hospital Laboratories, Commercial /
Private Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 127: Russia 15-Year Perspective for Therapeutic Drug
Monitoring by End-Use - Percentage Breakdown of Value Sales for
Hospital Laboratories, Commercial / Private Laboratories and
Other End-Uses for the Years 2012, 2021 & 2027

REST OF EUROPE
Table 128: Rest of Europe Recent Past, Current & Future
Analysis for Therapeutic Drug Monitoring by Product -
Consumables and Equipment - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 129: Rest of Europe Historic Review for Therapeutic Drug
Monitoring by Product - Consumables and Equipment Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 130: Rest of Europe 15-Year Perspective for Therapeutic
Drug Monitoring by Product - Percentage Breakdown of Value
Sales for Consumables and Equipment for the Years 2012, 2021 &
2027

Table 131: Rest of Europe Recent Past, Current & Future

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033114/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001